AS, H., NM, E., EM, M., OA, H., SS, B., & E, E. (2022). Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades. Life sciences, 304, 120695. https://doi.org/10.1016/j.lfs.2022.120695
Chicago Style (17th ed.) CitationAS, Hendawy, El-Lakkany NM, Mantawy EM, Hammam OA, Botros SS, and El-Demerdash E. "Vildagliptin Alleviates Liver Fibrosis in NASH Diabetic Rats via Modulation of Insulin Resistance, Oxidative Stress, and Inflammatory Cascades." Life Sciences 304 (2022): 120695. https://doi.org/10.1016/j.lfs.2022.120695.
MLA (9th ed.) CitationAS, Hendawy, et al. "Vildagliptin Alleviates Liver Fibrosis in NASH Diabetic Rats via Modulation of Insulin Resistance, Oxidative Stress, and Inflammatory Cascades." Life Sciences, vol. 304, 2022, p. 120695, https://doi.org/10.1016/j.lfs.2022.120695.